Los Angeles Times @latimes Bringing L.A. to the world and the world to L.A. Subscribe now: checkout2.latimes.com/ Jun. 19, 2019 1 min read

Germany doesn’t have a government-run healthcare system. But Europe’s largest nation has still found a way to rein in drug prices.

The U.S. can take note.  https://lat.ms/2IqUFzf 

Total German spending on retail drugs is still among the highest in Europe, topping $775-per-person annually.

But that’s still considerably lower than in the U.S., where per-person spending exceeds $1,200, the highest in the world.  https://lat.ms/2IqUFzf 

U.S. politicians are often reluctant to look overseas to solve American healthcare problems. But as pressure builds on the Trump administration and Congress to rein in skyrocketing drug prices, Europe’s largest nation offers useful lessons.  https://lat.ms/2XUX8r2 

Germany relies on a transparent system for pricing medications: Insurers negotiate collectively with drug manufacturers and all prices are made public. The capped price for most prescriptions is 10 Euros, or roughly $11 USD.  https://lat.ms/2IqUFzf 

There are strict limits on how much patients pay for their medical care, a major difference from the U.S., where deductibles are soaring. Co-pays are limited to 10 Euros per prescription, even for expensive cancer drugs. There are no deductibles.  https://lat.ms/2WLNE42 

With medical costs rising for everyday Americans, could the U.S. learn from the German healthcare system?

Read more from @NoamLevey:  https://lat.ms/2IqUFzf 

You can follow @latimes.


Tip: mention @threader_app on a Twitter thread with the keyword “compile” to get a link to it.

Enjoy Threader? Sign up.